Navigation Links
IRIDEX Reports 2012 Second Quarter Results
Date:8/2/2012

$4.2 million and $4.4 million and anticipates being at breakeven for operating income.

President and CEO Dominik Beck said, "Demand and delivery of both capital equipment and consumable products remained stable in the second quarter with a number of promising improvements.  On the consumables side of the business, sales of our glaucoma product continued to strengthen following a focused marketing campaign that began at the beginning of 2012.  In addition, our licensing and distribution partnership is delivering strong results and current indications are for this to continue. This success is a validation of our M&A strategy as the small acquisition of RetinaLabs has already paid for itself several times over, and we anticipate similar impacts from our Ocunetics acquisition following the planned product launch in early 2014."

Beck continued, "As we indicated last quarter, we anticipate that our increased investments in people and programs across the organization will drive overall sales growth in the second half of the year, and we intend to balance our investments in line with our revenue growth to maintain profitability for the year.

"The most exciting marketing feedback I have received this quarter, for both clinical and investor audiences, is the accelerating adoption of MicroPulse™ for treatment of diabetic macular edema (DME). We have been working on economic models that make sense to the doctor and healthcare systems to encourage their adoption of this new treatment paradigm that has multiple benefits to the patient, and we are starting to see these models impact the purchasing decisions of our customer base. Furthermore, our experiences in DME have led us to explore opportunities for MicroPulse in the treatment of glaucoma. We are working with a number of key opinion leaders in glaucoma who have begun to explore how our minimally invasive technology can improve on the current standard of care for treating glaucoma.
'/>"/>

SOURCE IRIDEX Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. IRIDEX Announces Second Quarter 2012 Conference Call and Release Date
2. IRIDEX Reports 2012 First Quarter Results
3. IRIDEX Introduces Non-Invasive MicroPulse™ Therapy for Glaucoma
4. New Medical Device Market Research Reports Tracking over $9.5 Billion of Annual Sales Volume Now Available from GII
5. GP Strategies Reports Record Revenue of $102 Million for Second Quarter of 2012
6. Par Pharmaceutical Companies Reports Second Quarter 2012 Results
7. Henry Schein Reports Record Second Quarter Results
8. Consumer Reports Investigates Vitamins And Supplements: Ten Dangers That May Surprise You
9. STAAR Surgical Reports Second Quarter 2012 Financial Results
10. Thoratec Reports Second Quarter Results
11. Masimo Reports Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... Research and Markets ( http://www.researchandmarkets.com/research/t63pbj/medical_device ) has announced the ... Markets Seminar" conference to their offering. ... well established, the next growth area is ... with other countries in this region have all implemented, ... medical device regulations. This seminar will provide a comprehensive ...
(Date:7/27/2015)... and MENLO PARK, Calif. ... Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the ... commercializing proven cancer therapies in new orphan drug ... from institutional and accredited investors for a registered ... common stock and 3.35 million common stock purchase ...
(Date:7/27/2015)... , July 27, 2015  Cardica, Inc. (Nasdaq: CRDC ... its fiscal fourth quarter ended June 30, 2015, on Thursday, ... host a conference call at 4:30 p.m. Eastern Time to ... company,s business. Conference Call Details To access ... p.m. Eastern Time via phone, please dial 877-703-6106 from ...
Breaking Medicine Technology:Medical Device Regulation in Asia/Pacific Markets Seminar: London, UK - 21st, 22nd of September 2015 2DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering 2DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering 3Cardica To Announce Fiscal 2015 Fourth Quarter Financial Results On Thursday, August 6, 2015 2
... Candidate to Enter Clinical ... Studies in ... today it has initiated a Phase I clinical study of a ... safety, tolerability, and systemic pharmacokinetics of a topical,patch formulation of diclofenac ...
... Antisense Drug Targeting Glucagon Receptor for Treatment ... of Type 2 ... ) announced today it has earned $5,million from Ortho-McNeil, Inc. (OMI), a ... Phase 1,clinical trial of ISIS 325568. The collaboration between Isis and ...
Cached Medicine Technology:Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch 2Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch 3Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568 2Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568 3
(Date:7/27/2015)... ... 27, 2015 , ... On July 14, 2015, Harper’s Bazaar Magazine in an ... skin issues such as stretch marks , fine lines , and ... treatment options listed include lasers, ultrasound, radio frequency, Botox, and dermal fillers. It is ...
(Date:7/27/2015)... , ... July 27, 2015 , ... Eugene Batelli, D.P.M., ... accomplished athlete. “The patient is high-end athlete, whose accomplishments include running in 27 ... of Achilles tendon pain, which was diagnosed as tendinitis. I did an ultrasound ...
(Date:7/27/2015)... ... July 27, 2015 , ... The Maricopa Community Colleges today ... foster care system to get into and complete college. , The “Bridging Success ... an event today with partners from across the valley. , The initiative advisory board ...
(Date:7/27/2015)... New York, NY (PRWEB) , ... July 27, 2015 , ... ... North American tour. He will be performing for one additional night at each ... can add promo/coupon code DAVID-GILMOUR-2016 for added savings. , David Gilmour’s 2016 North America ...
(Date:7/27/2015)... , ... July 27, 2015 ... ... Global Calcium Propionate industry is a professional and in-depth research report. The ... industry chain structure, international market analysis etc. This report covers the global ...
Breaking Medicine News(10 mins):Health News:The Latest Treatment Options for Seven Common Skin Issues 2Health News:NJ Top Docs Presents, Dr. Eugene Batelli of Metropolitan Ankle & Foot Care Specialists 2Health News:NJ Top Docs Presents, Dr. Eugene Batelli of Metropolitan Ankle & Foot Care Specialists 3Health News:Maricopa Community Colleges Launch Program To Help Youth In Foster Care Finish College 2Health News:Maricopa Community Colleges Launch Program To Help Youth In Foster Care Finish College 3Health News:Cheap David Gilmour Tickets at Madison Square Garden (MSG), Air Canada Center, United Center and Hollywood Bowl: Additional Dates for David Gilmour Go On Sale Today 2Health News:Calcium Propionate Market Global Suppliers and Manufacture Analysis 2Health News:Calcium Propionate Market Global Suppliers and Manufacture Analysis 3
... cold virus to deliver pluripotent cells circumvents safety concerns, ... Researchers report that they have sidestepped a major technical ... adult cells. , A team of Boston scientists developed ... -- which are functionally similar to embryonic stem cells, ...
... to Eat Right, Move More and ... Milk Their Diets, NASHVILLE, Tenn., ... of different fad diets -- which seem to go in,and out of fashion ... three Americans -- including 27 percent of,Nashville residents -- remain overweight or obese., ...
... You Pink" campaign warns of "pinkwashing"., SAN ... respected watchdog of the breast cancer movement - ... Pink" campaign. The annual consumer,education campaign offers tips ... ( http://www.thinkbeforeyoupink.org ), This year,s campaign warns ...
... PHILADELPHIA, Sept. 25 The Council on Compulsive,Gambling of ... Systems Inc., and the Western Psychiatric Institute and,Clinic, our ... East Holiday Inn at 4751 Linden Road will host ... The Conference will be opened by,Tom Wolf, Secretary of ...
... 25 Sept. 26, 2008, marks the,100th anniversary ... 1908,Jersey City, N.J., was the first city in ... water. Since then, incidences of,waterborne diseases have plummeted, ... Director Gary Zimmerman,offers the following comments on behalf ...
... Employees Proves Worksite Wellness Programs Work, DALLAS, Sept. ... been recognized by the American Heart Association,s,Start! Fit-Friendly Companies ... place -- a 20 percent increase over last year., ... to get,Americans walking. Most adult Americans spend a majority ...
Cached Medicine News:Health News:Researchers Report Stem Cell Advance 2Health News:Researchers Report Stem Cell Advance 3Health News:Researchers Report Stem Cell Advance 4Health News:Message to Tennessee Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Tennessee Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Breast Cancer Action Targets Yoplait in 'Think Before You Pink' Campaign; Calls for Yogurt Without Artificial Hormones 2Health News:Statewide Gambling Conference -- Series of 'Firsts' -- Begins 9-30-08 2Health News:AWWA Marks 100th Anniversary of Chlorine Disinfection 2Health News:American Heart Association Announces Start! Fit-Friendly Companies 2Health News:American Heart Association Announces Start! Fit-Friendly Companies 3
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: